Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results ; volume:15 ; number:1 ; day:14 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
Radiation oncology ; 15, Heft 1 (14.7.2020), 1-8, 12.2020
- Urheber
-
Vuolukka, Kristiina
Auvinen, Päivi
Tiainen, Erno
Palmgren, Jan-Erik
Heikkilä, Janne
Seppälä, Jan
Aaltomaa, Sirpa
Kataja, Vesa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01608-1
- URN
-
urn:nbn:de:101:1-2020091021160391510747
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:53 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vuolukka, Kristiina
- Auvinen, Päivi
- Tiainen, Erno
- Palmgren, Jan-Erik
- Heikkilä, Janne
- Seppälä, Jan
- Aaltomaa, Sirpa
- Kataja, Vesa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stereotactic body radiotherapy for organ-confined prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy for organ-confined prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy for organ-confined prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes